TREANDA

This brand name is authorized in Canada, Hong Kong, United States

Active ingredients

The drug TREANDA contains one active pharmaceutical ingredient (API):

1 Bendamustine UNII 981Y8SX18M - BENDAMUSTINE HYDROCHLORIDE

Bendamustine is an alkylating antitumour agent with unique activity. The antineoplastic and cytocidal effect of bendamustine is based essentially on a cross-linking of DNA single and double strands by alkylation. As a result, DNA matrix functions and DNA synthesis and repair are impaired. Read about Bendamustine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TREANDA Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01AA09	Bendamustine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02392550, 02392569
Country: HK	Department of Health Drug Office	Identifier(s): 59067, 62300
Country: US	FDA, National Drug Code	Identifier(s): 63459-390, 63459-391